List of insiders holdings for Regulus Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| MOTT DAVID M 10% Owner | 2019-12-26 17:01:47 | 0 15,922,758 | 15,922,758 | Form 4 |
| BARRIS PETER J 10% Owner | 2019-12-26 16:57:51 | 0 15,922,758 | 15,922,758 | Form 4 |
| Viswanathan Ravi 10% Owner | 2017-07-31 18:00:27 | 0 10,989,010 | 10,989,010 | Form 3 |
| Sakoda Jon 10% Owner | 2017-07-31 17:59:06 | 0 10,989,010 | 10,989,010 | Form 3 |
| Puttagunta Chetan 10% Owner | 2017-07-31 17:58:37 | 0 10,989,010 | 10,989,010 | Form 3 |
| Growth Equity Opportunities V LLC New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC Former 10% Owner | 2024-03-18 21:13:19 | 6,533,102 0 | 6,533,102 | Form 13D |
| DENNER ALEXANDER J Sarissa Capital Management LP Sarissa Capital Offshore Master Fund LP Sarissa Capital Catapult Fund LLC Sarissa Capital Hawkeye Fund LP 10% Owner | 2020-01-03 21:53:43 | 0 6,506,633 | 6,506,633 | Form 4 |
| MARAGANORE JOHN Director 10% Owner | 2012-10-11 19:52:01 | 0 6,150,500 | 6,150,500 | Form 4 |
| ASTRAZENECA PLC ASTRAZENECA AB 10% Owner | 2015-01-09 16:31:30 | 4,250,000 0 | 4,250,000 | Form 13G |
| Sarissa Capital Offshore Master Fund LP 10% Owner | 2020-05-08 20:03:50 | 4,039,390 0 | 4,039,390 | Form 4 |
| ISIS PHARMACEUTICALS INC PARSHALL B LYNNE 10% Owner | 2015-07-31 17:19:59 | 2,843,172 0 | 2,843,172 | Form 13D |
| ISIS PHARMACEUTICALS INC 10% Owner | 2015-07-31 17:19:59 | 2,843,172 0 | 2,843,172 | Form 13D |
| Hagan Joseph P Chief Executive Officer | 2024-05-21 16:21:26 | 990,000 0 | 990,000 | Form 4 |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner | 2024-11-14 16:32:07 | 883,844 0 | 883,844 | Form 13G |
| Klassen Preston President & Head of R & D | 2024-05-21 16:22:09 | 528,000 0 | 528,000 | Form 4 |
| CALSADA CRISPINA Chief Financial Officer | 2024-05-21 16:21:09 | 462,000 0 | 462,000 | Form 4 |
| GRINT PAUL C President & CEO | 2017-02-23 17:21:28 | 410,000 0 | 410,000 | Form 4 |
| Aker Christopher Ray Sr. VP & General Counsel | 2024-05-21 16:20:55 | 363,000 0 | 363,000 | Form 4 |
| XANTHOPOULOS KLEANTHIS G President and CEO | 2015-04-21 19:06:32 | 214,637 80,216 | 294,853 | Form 4 |
| Sarissa Capital Master Fund II LP 10% Owner | 2020-05-08 20:01:59 | 158,023 0 | 158,023 | Form 3 |
| WRIGHT TIMOTHY MICHAEL Chief R & D Officer | 2019-02-06 16:52:33 | 102,893 0 | 102,893 | Form 4 |
| Drygin Denis Chief Scientific Officer | 2022-03-01 17:58:56 | 100,000 0 | 100,000 | Form 4 |
| Deeg Mark Albert Chief Medical Officer | 2018-05-21 16:39:25 | 100,000 0 | 100,000 | Form 4 |
| Simeonidis Simos Director | 2022-06-10 16:16:01 | 90,000 0 | 90,000 | Form 4 |
| FOLETTA MARK G Director | 2017-12-06 19:42:15 | 81,910 0 | 81,910 | Form 4 |
| Szekeres David Leslie Chief Business Officer & GC | 2014-12-04 19:37:16 | 81,101 0 | 81,101 | Form 4 |
| Chevallard Daniel R. Chief Financial Officer | 2019-07-02 17:41:20 | 77,870 0 | 77,870 | Form 4 |
| Menzel Garry E COO & Executive VP, Finance | 2012-12-13 19:33:25 | 75,000 0 | 75,000 | Form 4 |
| Witz Pascale Director | 2024-05-21 16:23:37 | 60,000 0 | 60,000 | Form 4 |
| PAPADOPOULOS STELIOS Director | 2024-05-21 16:23:54 | 60,000 0 | 60,000 | Form 4 |
| Huang Alice Shih-hou Director | 2024-05-21 16:22:25 | 60,000 0 | 60,000 | Form 4 |
| BALTIMORE DAVID Director | 2024-05-21 16:22:15 | 60,000 0 | 60,000 | Form 4 |
| RASTETTER WILLIAM H Director | 2024-05-21 16:24:04 | 0 60,000 | 60,000 | Form 4 |
| Rosen Hugh Director | 2024-05-21 16:23:14 | 60,000 0 | 60,000 | Form 4 |
| Nunn Jason Raleigh Director | 2024-05-21 16:23:00 | 60,000 0 | 60,000 | Form 4 |
| WILLIAMS DOUGLAS E Director | 2016-06-03 16:54:12 | 36,620 0 | 36,620 | Form 4 |
| Greene Barry E Director 10% Owner | 2012-11-07 18:50:58 | 25,000 0 | 25,000 | Form 4 |
| CROOKE STANLEY T Director 10% Owner | 2012-11-07 19:05:40 | 25,000 0 | 25,000 | Form 4 |
| CARTER BRUCE L A Director | 2015-06-26 17:41:55 | 17,500 0 | 17,500 | Form 4 |
| Collier Kathryn J Director | 2024-07-29 16:18:02 | 6,740 0 | 6,740 | Form 4 |
| Walker Paul Edward Former 10% Owner | 2021-03-16 20:46:58 | 0 0 | 0 | Form 4 |
| Sonsini Peter W. Former 10% Owner | 2021-03-16 20:46:10 | 0 0 | 0 | Form 4 |
| SANDELL SCOTT D Former 10% Owner | 2021-03-16 20:45:14 | 0 0 | 0 | Form 4 |
| MAKOWER JOSHUA Former 10% Owner | 2021-03-16 20:44:11 | 0 0 | 0 | Form 4 |
| Makhzoumi Mohamad Former 10% Owner | 2021-03-16 20:43:23 | 0 0 | 0 | Form 4 |
| Florence Anthony A. Jr. Former 10% Owner | 2021-03-16 20:42:31 | 0 0 | 0 | Form 4 |
| Chang Carmen Former 10% Owner | 2021-03-16 20:41:35 | 0 0 | 0 | Form 4 |
| Behbahani Ali Former 10% Owner | 2021-03-16 20:40:36 | 0 0 | 0 | Form 4 |
| BASKETT FOREST Former 10% Owner | 2021-03-16 20:39:41 | 0 0 | 0 | Form 4 |
| ALNYLAM PHARMACEUTICALS INC. 10% Owner | 2017-08-09 17:01:58 | 0 0 | 0 | Form 13G |
| Gibson Neil W Chief Scientific Officer | 2015-01-30 17:45:43 | 0 0 | 0 | Form 4 |
| Sanofi 10% Owner | 2020-02-10 08:07:02 | 0 0 | 0 | Form 13G |